Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients
Clinical trial NCT02182479 · COMPLETED
Trial details
- NCT number
- NCT02182479
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-04-01
- Primary completion
- 1999-06-01
- Enrollment
- 631
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.